High tPA-expression in primary melanoma of the limb correlates with good prognosis (Q36692014)

15 August 2017

High tPA-expression in primary melanoma of the limb correlates with good prognosis (English)

1 reference

15 August 2017

Ferrier CM

1

1 reference

15 August 2017

Suciu S

2

1 reference

15 August 2017

van Geloof WL

3

1 reference

15 August 2017

Straatman H

4

1 reference

15 August 2017

Eggermont AM

5

1 reference

15 August 2017

Koops HS

6

1 reference

15 August 2017

Kroon BB

7

1 reference

15 August 2017

Lejeune FJ

8

1 reference

15 August 2017

Kleeberg UR

9

1 reference

15 August 2017

van Muijen GN

10

1 reference

15 August 2017

Ruiter DJ

11

1 reference

15 August 2017

language of work or name

English

0 references

publication date

1 November 2000

1 reference

British Journal of Cancer

15 August 2017

1 reference

15 August 2017

83

1 reference

15 August 2017

10

1 reference

15 August 2017

1351-1359

1 reference

https://scigraph.springernature.com/pub.10.1054/bjoc.2000.1460

15 August 2017

0 references

cites work

Angiostatin generation by human tumor cell lines: involvement of plasminogen activators.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2408793

Prognostic value of tissue-type plasminogen activator (tPA) and its complex with the type-1 inhibitor (PAI-1) in breast cancer

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2408793

Urokinase plasminogen activator: a prognostic marker in multiple types of cancer

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2408793

Actions of heparin that may affect the malignant process

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2408793

Plasminogen activator inhibitor type 2 in breast cancer.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2408793

Levels of plasminogen activator inhibitor type 1 and urokinase plasminogen activator receptor in non-small cell lung cancer as measured by quantitative ELISA and semiquantitative immunohistochemistry

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2408793

Different roles for plasminogen activators and metalloproteinases in melanoma metastasis.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2408793

The plasminogen activation system in melanoma cell lines and in melanocytic lesions.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2408793

Differential biological significance of tissue-type and urokinase-type plasminogen activator in human breast cancer

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2408793

Angiogenin promotes invasiveness of cultured endothelial cells by stimulation of cell-associated proteolytic activities

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2408793

Prognostic role of urokinase-type plasminogen activator in human gliomas.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2408793

Prognostic significance of proteolytic enzymes in human brain tumors

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2408793

Activation of blood coagulation in cancer: Trousseau's syndrome revisited.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2408793

Comparison of immunohistochemistry with immunoassay (ELISA) for the detection of components of the plasminogen activation system in human tumour tissue

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2408793

Effect of steroid hormones and retinoids on the formation of capillary-like tubular structures of human microvascular endothelial cells in fibrin matrices is related to urokinase expression.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2408793

Ability of retroviral transduction to modify the angiogenic characteristics of RPE cells

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2408793

The urokinase-type plasminogen activator system in cancer metastasis: a review

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2408793

Plasminogen activators, their inhibitors, and urokinase receptor emerge in late stages of melanocytic tumor progression

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2408793

Differences in expression of metalloproteinases and plasminogen activators in murine melanocytes and B16 melanoma variants: lack of association with in vitro invasion.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2408793

Metastatic behavior of human melanoma cell lines in nude mice correlates with urokinase-type plasminogen activator, its type-1 inhibitor, and urokinase-mediated matrix degradation

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2408793

Clinical relevance of the urokinase-type and tissue-type plasminogen activators and of their type 1 inhibitor in breast cancer

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2408793

Cell-induced potentiation of the plasminogen activation system is abolished by a monoclonal antibody that recognizes the NH2-terminal domain of the urokinase receptor

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2408793

Correlates of urokinase-type plasminogen activator in colorectal cancer: positive relationship with nm23 and c-erbB-2 protein expression.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2408793

Tumor-associated proteases and inhibitors in gastric cancer: analysis of prognostic impact and individual risk protease patterns

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2408793

Induction of primary cutaneous melanocytic neoplasms in urokinase-type plasminogen activator (uPA)-deficient and wild-type mice: cellular blue nevi invade but do not progress to malignant melanoma in uPA-deficient animals.

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2408793

Interaction of fibrinogen with murine melanoma cells: covalent association with cell membranes and protection against recognition by lymphokine-activated killer cells

5 September 2018

1 reference

12 December 2020

Generation of cell surface-bound plasmin by cell-associated urokinase-type or secreted tissue-type plasminogen activator: a key event in melanoma cell invasiveness in vitro

1 reference

12 December 2020

Indispensable role of tissue-type plasminogen activator in growth factor-dependent tube formation of human microvascular endothelial cells in vitro

1 reference

12 December 2020

Expression of plasminogen activators and their inhibitors in human pancreatic carcinoma: immunohistochemical study

1 reference

12 December 2020

The role of hemostasis and fibrinolysis in the metastatic spread of cancer

1 reference

12 December 2020

Tissue-type plasminogen activator, a new prognostic marker in breast cancer

1 reference

12 December 2020

Role of fibrin coagulation in protection of murine tumor cells from destruction by cytotoxic cells

1 reference

12 December 2020

Tissue plasminogen activator increases canine endothelial cell proliferation rate through a plasmin-independent, receptor-mediated mechanism

1 reference

12 December 2020

Urokinase type plasminogen activator receptor is a novel prognostic factor in breast cancer

1 reference

12 December 2020

A sensitive and robust assay for urokinase and tissue-type plasminogen activators (uPA and tPA) and their inhibitor type I (PAI-1) in breast tumor cytosols

1 reference

12 December 2020

Protease levels in breast, ovary, and other gynecological tumor tissues: prognostic importance in breast cancer

1 reference

12 December 2020

Expression of plasminogen activator inhibitor-2 in epithelial ovarian cancer: a favorable prognostic factor related to the actions of CSF-1

1 reference

12 December 2020

Urokinase-type plasminogen activator, its inhibitor, and its receptor in patients with upper urinary tract carcinoma

1 reference

12 December 2020

The expression of urokinase type plasminogen activator is a novel prognostic factor in dukes B and C colorectal cancer

1 reference

12 December 2020

Cellular localization of urokinase-type plasminogen activator, its inhibitors, and their mRNAs in breast cancer tissues

1 reference

12 December 2020

Prognostic impact of urokinase-type plasminogen activator (PA), PA inhibitor type-1, and tissue-type PA antigen levels in node-negative breast cancer: a prospective study on multicenter basis

1 reference

12 December 2020

Epitopes of components of the plasminogen activation system are re-exposed in formalin-fixed paraffin sections by different retrieval techniques

1 reference

12 December 2020

Hemostasis and malignancy

1 reference

12 December 2020

Prophylactic isolated limb perfusion for localized, high-risk limb melanoma: results of a multicenter randomized phase III trial. European Organization for Research and Treatment of Cancer Malignant Melanoma Cooperative Group Protocol 18832, the Wor

1 reference

12 December 2020

Plasminogen activator inhibitor-1 is an independent poor prognostic factor for survival in advanced stage epithelial ovarian cancer patients

1 reference

12 December 2020

Multifunctional potential of the plasminogen activation system in tumor invasion and metastasis (review)

1 reference

12 December 2020

Proteases in cutaneous melanoma

1 reference

12 December 2020

Quality control of immunohistochemical evaluation of tumour-associated plasminogen activators and related components. European BIOMED-1 Concerted Action on Clinical Relevance of Proteases in Tumour Invasion and Metastasis.

1 reference

12 December 2020

Prognostic significance of urokinase-type plasminogen activator expression in squamous cell carcinomas of the esophagus

1 reference

12 December 2020

Markers of melanocytic tumour progression

1 reference

12 December 2020

Impact of urokinase-type plasminogen activator and its inhibitor type 1 on prognosis in cervical cancer of the uterus

1 reference

12 December 2020

Plasminogen activation in melanocytic neoplasia

1 reference

12 December 2020

Urokinase-type plasminogen activator and outcome in Dukes' B colorectal cancer

1 reference

12 December 2020

Components of the plasminogen activation system in uveal melanoma—a clinico-pathological study

1 reference

12 December 2020

Urokinase receptor in breast cancer tissue extracts. Enzyme-linked immunosorbent assay with a combination of mono- and polyclonal antibodies

1 reference

12 December 2020

Association of immunohistochemical detection of urokinase-type plasminogen activator with metastasis and prognosis in colorectal cancer

1 reference

12 December 2020

Prognostic significance of three novel biologic factors in a clinical trial of adjuvant therapy for node-negative breast cancer

1 reference

12 December 2020

Effects of fibrin on the angiogenesis in vitro of bovine endothelial cells in collagen gel

1 reference

12 December 2020

Prognostic relevance of urokinase-type plasminogen activator (uPA) and plasminogen activator inhibitors PAI-1 and PAI-2 in gastric cancer

1 reference

12 December 2020

Prognostic value of the plasminogen activation system in patients with gastric carcinoma

1 reference

12 December 2020

Angiostatin induces and sustains dormancy of human primary tumors in mice

1 reference

12 December 2020

alpha 2-Antiplasmin and plasminogen activator inhibitors in healing human skin wounds

1 reference

12 December 2020

Identifiers

DOI

10.1054/BJOC.2000.1460

1 reference

Dimensions Publication ID

15 August 2017

0 references

1 reference

15 August 2017

1 reference